(MENAFN- Comserve)
New York, United States, Mar 10, 2022, 03:18 /Comserve / -- The global thiazide diuretics market is projected to grow with a moderate CAGR during the forecast period, i.e., 2022-2030.
Research Nester released a report titled “ Thiazide Diuretics Market : Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global thiazide diuretics market in terms of market segmentation by use, distribution channel, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global thiazide diuretics market is projected to grow with a moderate CAGR during the forecast period, i.e., 2022-2030 on account of the rise in occurrence of metabolic disorders worldwide and technological developments in the field of thiazide diuretics. In addition, high penetration of drugs for treating hypertension in the low and middle-income regions on an advanced scale is also estimated to drive market growth in the coming years.
Download Sample of This Strategic Report @
The market is segmented by use into hypertension, cardiovascular disorders, hepatic disorders, kidney disorders, and others. Among these segments, the hypertension segment is anticipated to hold the largest share during the forecast period owing to the greater prevalence rate of hypertension globally as compared to other conditions. Additionally, by distribution channel, the hospital pharmacies' segment is expected to grow significantly as a substantial share of the population with hypertension and related disorders prefer hospital facilities for treatment worldwide.
On the basis of region, the global thiazide diuretics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, Asia Pacific's market is projected to grow at the highest CAGR throughout the forecast period owing to the rising incidences of hypertension-related medical conditions among the population in the region.
Rising Incidences of Metabolic Disorders and Technological Developments in the Field of Thiazide Diuretics to Drive Market Growth
The rapid growth in ageing population and the changes in lifestyle patterns have given way to the prevalence of various cardiovascular, hepatic, and kidney related disorders among the population on a global scale which has steered the demand for drugs used for the treatment of these conditions. This is considered to be a crucial factor expected to boost the market growth in the upcoming years.
Request a Sample Copy of Concerned Market Report @
However, the stringent regulatory procedures and harmful effects of the ionic imbalance caused by the use of thiazide diuretics are some of the factors that are estimated to restrain market growth in the near future.
This report also provides the existing competitive scenario of some of the key players of the global thiazide diuretics market which includes company profiling of Pfizer Inc., Merck Sharp & Dohme Corp., Sanofi SA, Bayer AG, Centaur Pharmaceuticals Pvt. Ltd., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Novartis AG, Boehringer Ingelheim GmbH, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global thiazide diuretics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Curious about this latest version of report? Obtain Report Details @
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
MENAFN10032022004694010674ID1103824826
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.